Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;25(3):166–171. [Article in Spanish] doi: 10.1016/S0212-6567(00)78481-2

Prevalencia de diabetes mellitus y su asociación a otros factores de riesgo cardiovascular en la provincia de Albacete

Prevalence of Diabetes Mellitus and its Relationship with Cardiovascular Risk in the Population of Albacete

B Rodríguez Paños 1,*, C Sanchis 1, F García Gosálvez 1, JA Divisón 1, LM Artigao 1, J López Abril 1, F Naharro 1, A Puras 1
PMCID: PMC7675791  PMID: 10730440

Abstract

Objective

To find the prevalence of DM in the population of Albacete, and their relationship with other risk factors.

Desing

A descriptive cross-sectional population study.

Setting

Community setting in the province of Albacete.

Participants

A sample of 2121 peopel over 18 (843 from the capital and 1278 from the rest of the province) was selected through strtified random sampling.

Measurements and main results

Appointments were made by mail. All those attending underwent anamnesis, a physical examination, EKG and basic analytic test. 1263 people older than 18 years were studied.

The prevalence of DM observed with WHO criteria was 6.7% (95% CI, 5.9%-7.4%), of wich 6.5% corresponded to known DM and only 0.2% to unknown. If ADA criteria were used, the prevalence was 9.8%.

We found association between DM and age, obesity, hypertension, hyperlipaemia, low HDL-c, high levels of fibrinogen, left ventricular hypertophy, arrhythmias and personal history of ischemic cardiopathy and peripheric arteriopathy.

Conclusions

DM is a highly prevalent pathology in Albacete. We consider necesary to standard epidemiologycal methods that allow us to know the real situation of DM in our contry.

Other cardiovascular risk factors are more prevalent in diabetical patients, increasing their cronary risk. The control of modificable factors is fundamental to avoid as possible the chronic complications of the disease.

Key words: Diabetes, Prevalence, Cardiovascular risk

Bibliografía

  • 1.Diabetes Care and Reseache in Europe The Sant Vincent Declaration. G Ital Diabetal. 1990;10(Supl):143–144. [Google Scholar]
  • 2.McCarty D., Zimmet P. Diabetes 1994 to 2010: global estimates and projections. Melbourne: International Diabetes Institute. 1994 [Google Scholar]
  • 3.Diabetes Mellitus Report of a WHO Study Group. Technical Report Series 727. Ginebra: OMS, 1985 [PubMed] [Google Scholar]
  • 4.Estadísticas de Salud 1978-1987. Información sanitaria y epidemiológica. Madrid: Ministerio de Sanidad y Consumo.
  • 5.Puig Domingo M, Leira Hidalgo A. Guía de atención precoz y tratamiento de la diabetes mellitus, 5-7.
  • 6.Report of the Expert Committee on the Diagnosis and Classification. Diabetes Care 20 (7): 1183. [DOI] [PubMed]
  • 7.Identificación de importancia relativa de los factores de riesgo cardiovascular. Riesgos de la hiperlipidemia. Riesgos de la HTA. Riesgos de la intolerancia a la glucosa. Riesgos de la obesidad. Clínicas Cardiológicas de Norteamérica. 1986 [Google Scholar]
  • 8.Fuller J.H., Shipley M.J., Rose G., Jarrett R.J., Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: The White Hall Study. Br Med J. 1983;287:867–870. doi: 10.1136/bmj.287.6396.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ferrannini E., Bzziglioli G., Bonadona R. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350–358. doi: 10.1056/NEJM198708063170605. [DOI] [PubMed] [Google Scholar]
  • 10.Reaven G.M. Rol of insulin resistance in human desease. Diabetes. 1988;37:1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  • 11.Assmann G., Schulte H., Cullen P. New and classical risk factors. The Münster study (procam) Eur J Med Res. 1997;2(6):237–242. [PubMed] [Google Scholar]
  • 12.Franch Nadal J., Álvarez Torrices J.C., Álvarez Guisasola F., Diego Domínguez F., Hernández Mejía R., Cueto Espinar A. El diagnóstico de la diabetes mellitus en los estudios epidemiológicos. Aten Primaria. 1991;8:465–470. [PubMed] [Google Scholar]
  • 13.Goday A., Serrano Ríos M. Epidemiología de la diabetes mellitus en España. Revisión crítica y nuevas perspectivas. Med Clin (Bar) 1994;102:306–315. [PubMed] [Google Scholar]
  • 14.Silva L.C. Muestreo para la investigación en ciencias de la salud. Madrid: Díaz de Santos, 1993;145 [Google Scholar]
  • 15.Sanchis C., López Abril J., Artigao L.M. Patología circulatoria y factores de riesgo vascular en la Zona Básica de Salud- III de Albacete. In: Gómez Ruiz F.T., editor. Atención al paciente vascular en atención primaria. Uriach; Barcelona:: 1991. pp. 53–56. [Google Scholar]
  • 16.National Diabetes Data Group Classification and diagnosis of diabets mellitus and other cathegories of glucosa intolerance. Diabetes. 1979;28:1039–1057. doi: 10.2337/diab.28.12.1039. [DOI] [PubMed] [Google Scholar]
  • 17.Bayés A. Ed. Científico Médica; Barcelona:: 1986. Fundamentos de electrocardiografía; pp. 95–105. [Google Scholar]
  • 18.Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. The Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNC) Arch Intern Med. 1993;153:154–183. [PubMed] [Google Scholar]
  • 19.Wilson P.W.F., Castelli W.P., Kannel W.B. Coronary risk predictor in adults (Framingham heart study) Am J Cardiol. 1987;59:91–94. doi: 10.1016/0002-9149(87)90165-2. [DOI] [PubMed] [Google Scholar]
  • 20.Pallardo Sánchez L.F., Ferré C., Puertas L., Pallardo L.F., Matute J.L. Prevalencia de morbilidad diabética conocida en la población rural española en 1978. Rev Clin Esp. 1980;159:243–249. [PubMed] [Google Scholar]
  • 21.Figuerola D., Castell C., Lloveras G. La diabetes en España. Análisis de la prevalencia y atención médica según el consumo de fármacos y material de autocontrol. Med Clin (Barc) 1998;91:401–405. [PubMed] [Google Scholar]
  • 22.Franch Nadal J., Álvarez Torrices J.C., Álvarez Guisasola F., Diego Domínguez F., Hernández Mejía R., Cueto Espinar A. Epidemiología de la diabetes mellitus en la provincia de León. Med Clin (Barc) 1992;98:607–611. [PubMed] [Google Scholar]
  • 23.Rodríguez-Miñón J.L., Gaona T., Poveda P. Epidemiologie du diabetes. Cah Med (Europa Medica) 1970;2:787. [PubMed] [Google Scholar]
  • 24.Bayo J., Sola C., García F., Latorre P.M., Vázquez J.A. Prevalencia de la diabetes mellitus no dependiente de la insulina en Lejona (Vizcaya) Med Clin (Barc) 1993;101:609–612. [PubMed] [Google Scholar]
  • 25.Tamayo-Marco B., Faure-Nogueras E., Roche-Asensio M.J., Rubio-Calvo E., Sánchez-Oriz E., Salvador-Olivan J.A. Prevalence of diabetes and impaired glucose tolerance in Aragon, Spain. Diabetes Care. 1997;20(4):534–536. doi: 10.2337/diacare.20.4.534. [DOI] [PubMed] [Google Scholar]
  • 26.Goday A., Castell C., Lloveras G. Los registros de diabetes: una necesidad actual. Med Clin (Bar) 1993;101:413–436. [PubMed] [Google Scholar]
  • 27.Goday Arnó A. Epidemiología de la diabetes tipo I ¿una vía hacia la prevención de la enfermedad? Med Clin (Bar) 1990;95:178–182. [PubMed] [Google Scholar]
  • 28.Pallardo Peinado L.F., Matute J.L. La morbilidad diabética conocida en la población rural de España. Rev Clin Esp. 1965;99:357–370. [PubMed] [Google Scholar]
  • 29.The Working Group of Hypertension in Diabetes Statement on hypertension in diabetes mellitus: Final report. Arch Int Med. 1987;147:830–842. [PubMed] [Google Scholar]
  • 30.Chrirstlieb A.R., Krowleski A.S., Warram J.M. Current concepts of pathophysiology and treatment in the patien whith hypertension and diabetes mellitus. In: Krall L.P., editor. World book of diabetes in practice. Elsevier; Nueva York:: 1988. pp. 260–265. 3. [Google Scholar]
  • 31.Modn M., Halkin H., Almog S., Lusky A., Eshkol A., Shefy M. Hyperinsulinemia. A link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985;75:809–817. doi: 10.1172/JCI111776. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Erkelens D.W. Lipids, lipoproteins and atherosclerosis in diabetes mellitus. In: Galloway J.A., Potvin J.H., Schumann C.R., editors. Lilly Research Lab; Indianápolis:: 1988. [Google Scholar]
  • 33.Orchard T.J. Dyslipoproteinemia and diabetes. Endocrinol Metab Clin North Am. 1990;19:361–380. [PubMed] [Google Scholar]
  • 34.West K.M., Ahuja M.M., Bennett P.H., Czyzyk K., De Acosta O.M., Fuller J.H. The role of circulating glucosa and triglycerid concentrations and their interactions with other «risk factors» as determinants of arterial disease in nine diabetics population samples from the WHO multinational study. Diabetes Care. 1983;6:361–369. doi: 10.2337/diacare.6.4.361. [DOI] [PubMed] [Google Scholar]
  • 35.Fontbonne A., Eschwege E., Cambien F., Richard J.L., Ducimetiere P., Thibult N. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: Results from the eleven years follow-up of the Paris Prospective Study. Diabetologia. 1989;32:300–304. doi: 10.1007/BF00265546. [DOI] [PubMed] [Google Scholar]
  • 36.Ferranini E., Haffner S.M., Mitchel B.D., Storn M.P. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrom. Diabetologia. 1991;34:416–422. doi: 10.1007/BF00403180. [DOI] [PubMed] [Google Scholar]
  • 37.Ceriello A. Fibrinogen plasma levels as a marker of thrombin activation in diabetes. Diabetes. 1994;43:430–432. doi: 10.2337/diab.43.3.430. [DOI] [PubMed] [Google Scholar]
  • 38.García M.J., McNamara P.M., Gordon T., Kannel W.B. Morbidity and mortality in diabetes in the Framingham population. Sixteen years follow-up study. Diabetes. 1974;23:105–111. doi: 10.2337/diab.23.2.105. [DOI] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES